XRP Healthcare M&A Holding Inc. is a Dubai-based healthcare acquisition and technology company, focused on AI-powered healthcare initiatives and pharmacy M&A across Africa. This entity is legally and operationally separate from XRP Healthcare LLC, which manages all XRPH token and digital asset activities. XRP Healthcare M&A Holding Inc. does not issue, control, or benefit from the XRPH token. For digital asset information, visit www.xrphtoken.com..
15/06/2025
Date: June 14, 2025
Time: 8 PM UTC
Host: Corey
Guest: Kain Roomes, CEO of XRP Healthcare
Corey:
Welcome, everyone, to this exclusive AMA with Kain Roomes, CEO of XRP Healthcare!
We’re thrilled to have you join us for what promises to be an insightful session.
Here’s how tonight went down:
We started with pre-submitted questions from the community
Kain answered them live
We closed with a few live chat questions (as time allowed)
Let’s jump into the key takeaways.
Kain: Absolutely not. The IPO, via our RTO listing on the TSXV, is funded through traditional private capital – not through token sales.
Kain: That’s our intention. XRPH powers utility, engagement, and alignment today – and post-IPO, we plan to deepen its role via integrations with pharmacies, access features, and services.
Kain: Through fiat-based subscription plans, in-app purchases, brand sponsorships, and healthcare integrations. XRPH tokens are not required for access.
Kain: No private sale. A public token sale occurred on the Sologenic DEX (Dec 2022 – Jan 2023). Founder allocations were structured with vesting and controls.
Kain: No. IPO access is regulated under Canadian securities law and cannot be tied to token holdings. That said, we’re exploring other ways to reward the XRPH community.
Kain: Tier 1 listings are costly. We’re preserving long-term value by prioritizing real growth (M&A, product rollout, IPO) over hype. Strategic listings will come in time.
Kain: XRPH has a fixed supply and no inflation. While no burn is active, supply optimization may be explored depending on adoption and legal guidance.
Kain: Major milestones include more pharmacy acquisitions, a global XRPH AI App rollout, Series A fundraising, and expanding across Africa and other markets.
Kain: Yes. A full audit of Pharma Ville (our acquired group) covering 2022–2024 was completed and submitted. All regulatory checks and due diligence have been cleared.
Kain: Yes. It’s already being used for payments in our Ugandan pharmacies. As our network grows, so will organic demand.
Kain: Yes – and it’s already underway. We’ve outperformed many projects in real-world exposure. Post-IPO, expect even more targeted campaigns.
Kain: Public listing brings global visibility, investor attention, and new users into the ecosystem – increasing utility and engagement via the XRPH token.
Kain: It will remain a utility token – powering healthcare access, payments, and potential loyalty and rewards mechanisms.
Kain: Absolutely. Influencer partnerships and healthcare-centric campaigns are in the roadmap, especially post-AI app expansion.
Kain: We’ve signed the Letter of Intent and are finalizing documentation. The Definitive Agreement and final TSXV steps are underway.
Kain: Yes. Dubai, the Middle East, and Europe are next. We’ve secured trademarks across the UK, UAE, and all 27 EU countries.
Kain: We’re licensed in the UAE and fully operational in Uganda. All TSXV audit and compliance requirements have been met.
Kain: ARC Group is our financial advisor for the TSXV listing. They’ve helped shape valuation and strategy but hold no equity.
Kain: A lean team in Dubai, pharmacy staff in Uganda, and a global network of consultants across legal, M&A, and development.
Kain: The stock supports corporate growth. The token supports community and service-level engagement – including payments, discounts, and app access.
Corey:
That wraps up our AMA with Kain Roomes!
A huge thank-you to Kain for the transparency and updates, and to all of you for being here.
Be sure to follow XRP Healthcare for more updates as they move toward their public listing and continue expanding their healthcare ecosystem.